Adimmune Corporation (TPE:4142)
Taiwan · Delayed Price · Currency is TWD 17.25
-0.05 (-0.29%)
Aug 19, 2026, 1:30 PM CST
Adimmune Market Cap
Adimmune has a market cap or net worth of 7.29 billion as of August 18, 2026. Its market cap has decreased by -0.86% in one year.
Market Cap
7.29B
Enterprise Value
8.28B
Revenue
1.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
17.25
ChartMarket Cap Chart
Since September 29, 2010, Adimmune's market cap has decreased from 11.10B to 7.29B, a decrease of -34.29%. That is a compound annual growth rate of -2.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 7.29B | -8.71% |
| Dec 31, 2025 | 7.99B | -5.72% |
| Dec 31, 2024 | 8.47B | -39.37% |
| Dec 29, 2023 | 13.97B | -7.97% |
| Dec 30, 2022 | 15.18B | -20.83% |
| Dec 30, 2021 | 19.18B | -20.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tanvex BioPharma | 9.88B |
| AP Biosciences | 9.84B |
| Polaris Group | 9.29B |
| TCM Biotech International | 9.00B |
| PharmaEngine | 8.49B |
| Locus Cell | 7.45B |
| Acepodia | 6.91B |
| Savior Lifetec | 6.35B |